'Going-to-have-cancerness': A study of living with increased risk of BRCA1 and BRCA2 mutations for six South Island women

Journal of Primary Health Care

Volumn 2, Issue 4, 2010, Pages 311-317

  Crump, Raewyn J ^a   Fitzgerald, Ruth P ^a   Legge, Michael ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Breast neoplasm; Genes BRCA1; Genes BRCA2; Qqualitative research; Risk

Indexed keywords

ADAPTIVE BEHAVIOR; ADULT; ARTICLE; ATTITUDE TO HEALTH; BREAST TUMOR; FAMILY HEALTH; FEMALE; FOLLOW UP; GENETIC PREDISPOSITION; GENETICS; HUMAN; MIDDLE AGED; MUTATION; NEW ZEALAND; PATIENT SATISFACTION; PSYCHOLOGICAL ASPECT; QUALITATIVE RESEARCH; RISK ASSESSMENT; TUMOR SUPPRESSOR GENE;

ADAPTATION, PSYCHOLOGICAL; ADULT; ATTITUDE TO HEALTH; BREAST NEOPLASMS; FAMILY HEALTH; FEMALE; FOLLOW-UP STUDIES; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOST TO FOLLOW-UP; MIDDLE AGED; MUTATION; NEW ZEALAND; PATIENT SATISFACTION; QUALITATIVE RESEARCH; RISK ASSESSMENT;

EID: 79952279292     PISSN: 11726164     EISSN: 11726156     Source Type: Journal    
DOI: 10.1071/hc10311     Document Type: Article

References (40)

1. Ministry of Health, new Zealand. Cancer in New Zealand: trends and projections 2000-2004 update. Pub Health intelligence Occasional Bulletin. 2004:49.
2. Parmet s, Lyn C, Glass Rd. Genetics and breast cancer. JAMA. 2004;292:522.
3. Evans dGR, Lalloo F. Risk assessment and management of high risk familial breast cancer. J Med Genet. 2002;39:865-871.
4. Narod sA, Foulkes Wd. BRCA1 and BRCA2: 1994 and beyond. nature Reviews: Cancer. 2004;4:665-676.
5. Anglian Breast Cancer study Group. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population based series of breast cancer cases. Brit J Cancer. 2000;83:1301-1308.
6. Blackwood MA, Weber BL. BRCA1 and BRCA2: from molecular genetics to clinical medicine. J Clin Oncol. 1998;16:1967-1977.
7. Thompson A, Brennan K, Cox A, et al. Evaluation of current knowledge limitations on breast cancer research: a gap analysis. Breast Cancer Res. 2008; 10: R26 (doi10.11.1186/bcr1983)
8. new Zealand Guidelines Group Management of Early Breast Cancer. Wellington: new Zealand Guidelines Group; 2009.
9. Morrow M, Gradishar W. Breast cancer. BMJ. 2002;324:410-414.
10. Press n, Reynolds s, Pinsky L, et al. 'That's like chopping off a finger because you're afraid it might get broken': disease and illness in women's views of prophylactic mastectomy. soc sci Med. 2005;61:1106-1117.
11. Pharoh PDP, day nE, duffy s, et al. Family history and the risk of breast cancer: a systematic review and meta-analysis. int J Cancer. 1997;71:800-809.
12. Chen s, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol. 2007;25:1329-1333.
13. Bouchard L, Blancquaert i, Eisinger F, et al. Prevention and genetic testing for breast cancer: variations in medical decisions. soc sci Med. 2004;58:1085-96.
14. Wideroff L, Freedman A, Olson L, et al. Physician use of genetic testing for cancer susceptibility: results of a national survey. Cancer Epidemiol Biomarkers Prev. 2003;12:295-303.
15. Pinkowish Md. Family physicians and referrals of low-risk women for BRCA1/2 genetic services. CA Cancer J Clin. 2009;59:70-72.
16. McCann s, Macauley d, Barnett Y. Genetic consultations in primary care: GPs' responses to three scenarios. scand J Prim Health Care. 2005;23:109-114.
17. Aalfs CM, smets E, de Haes H, Leschot n. Referral for genetic counselling during pregnancy: limited alertness and awareness about genetic risk factors among GPs. Fam Pract. 2003;20(2):135-141.
18. Tyler C, snyder C. Cancer risk assessment: examining the family physician's role. J Am Board Fam Med. 2006;19(5):468-544.
19. Calefato J, nippert i, Harris J, et al. Assessing educational priorities in genetics for general practitioners and specialists in five countries: factor structure of the genetic educational priorities (Gen-EP) scale. Genet Med. 2008;10(2):99-106.
20. Gorin s, Ashford A, Lantigua R, et al. Effectiveness of academic detailing on breast cancer screening among primary care physicians in an underserved community. J Am Board Fam Med. 2006;19(2):110-121.
21. Watson E, Clements A, Yudkin P, Rose P, Bukack C, Mackay J, Lucassen A, Austoker J. Evaluation of the impact of two educational interventions on GP management of familial breast/ovarian cancer cases: a cluster randomised controlled trial. Br J of Gen Pract. 2001;51(471):817-21.
22. Julian-Reynier C, nippert i, Calefato J, et al. Genetics in clinical practice: general practitioners' eduational priorities in European countries. Genet Med. 2008;10(2):107-113.
23. Barlow-stewart K, Gaff C. Working in partnership with support services in the era of the 'new genetics'. Med J Aust. 2003;178(10):515-519.
24. Grande G, Hyland F, Walter F, Kinmonth A. Women's views of consultations about familial risk of breast cancer in primary care. Patient Educ Couns. 2002;48(3):275-282.
25. Tolich M, davidson C. starting fieldwork: an introduction to qualitative research in new Zealand. Auckland: Oxford University Press; 2001.
26. Pinsky L, Culver J, Hull J, et al. Why should primary care physicians know about breast cancer genetics? West J Med. 2001 Sep;175(3):168-173.
27. Baars M, Henneman L, Ten K, deficiency of knowledge of genetics and genetic tests among general practitioners, gynaecologists and paediatricians a global problem. Genet Med. 2005;7(9):605-10.
28. Morse J. The significance of saturation. qual Health Res. 1995;5:147-149.
29. stake RE. Case studies. in: nK denzin and Ys Lincoln, editors. The sAGE handbook of qualitative research. Thousand Oaks: Sage; 2000.
30. American society for Clinical Oncology. Genetic testing for cancer susceptibility. J Clin Oncol. 2003;21:2397-2406.
31. Haynes dF. Follow-up of patients with early breast cancer. n Engl J Med. 2007;356:2505-2513.
32. Chlebowski RT, Kuller LH, Prentice RL, et al. Breast cancer after use of estrogen plus progestin in postmenopausal women. NEngl J Med. 2009;360:573-587.
33. Punglia MJ, Morrow M, Winer EP, Harris JR. Local therapy and survival in breast cancer. n Engl J Med. 2007;356:2399-2405.
34. Jasper MJ, Liebelt J, Hussey nd. Preimplantation genetic diagnosis for BRAC1 exon 13 duplication mutation using linked polymorphic markers resulting in a live birth. Prenat diagn. 2008 Apr;28(4):292-298.
35. Shapiro CL, Recht A. side effects of adjuvant treatment of breast cancer. n Engl J Med. 2001 Jun;344(26):1997-2008.
36. Smith iE, dowsett M. Aromatase inhibitors in breast cancer. n Engl J Med. 2003;348:2431-2442.
37. Ziegler L.D. Kroll S.S. Primary breast cancer after prophylactic mastectomy. Am J Clin Oncol. 1991 Oct;14(5):451-454.
38. Crump RJ. 'Going-to-have-cancerness' experiences of breast cancer genetic susceptibility. Unpublished Master of Health Science (Bioethics) thesis, University of Otago; 2005.
39. White S. McLeod D. Genetic testing: a survey of new Zealand general practitioners' knowledge and current practice. Prepared for the national Health Committee, General Practice department, Wellington school of Medicine and Health sciences, University of Otago, New Zealand; 2003.
40. Lerman C, Croyle RT, Tercyak KP, Harman H. Genetic testing: psychological aspects and implications. J Consult Clin Psychol. 2002 Jun;70(3):784-797.